Hester Biosciences Statistics

Total Valuation

Hester Biosciences has a market cap or net worth of INR 21.00 billion. The enterprise value is 23.40 billion.

Market Cap	21.00B
Enterprise Value	23.40B

Important Dates

The last earnings date was Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Aug 22, 2024

Share Statistics

Hester Biosciences has 8.51 million shares outstanding. The number of shares has increased by 7.41% in one year.

Current Share Class	n/a
Shares Outstanding	8.51M
Shares Change (YoY)	+7.41%
Shares Change (QoQ)	+15.49%
Owned by Insiders (%)	62.40%
Owned by Institutions (%)	0.37%
Float	2.35M

Valuation Ratios

The trailing PE ratio is 89.03.

PE Ratio	89.03
Forward PE	n/a
PS Ratio	6.60
PB Ratio	6.80
P/TBV Ratio	n/a
P/FCF Ratio	48.69
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.19, with an EV/FCF ratio of 54.25.

EV / Earnings	99.69
EV / Sales	7.39
EV / EBITDA	33.19
EV / EBIT	42.71
EV / FCF	54.25

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.78.

Current Ratio	1.75
Quick Ratio	0.87
Debt / Equity	0.78
Debt / EBITDA	3.64
Debt / FCF	5.66
Interest Coverage	5.47

Financial Efficiency

Return on equity (ROE) is 8.68% and return on invested capital (ROIC) is 5.71%.

Return on Equity (ROE)	8.68%
Return on Assets (ROA)	4.74%
Return on Capital (ROIC)	5.71%
Revenue Per Employee	4.93M
Profits Per Employee	365,561
Employee Count	642
Asset Turnover	0.47
Inventory Turnover	1.27

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+57.74%
50-Day Moving Average	2,409.29
200-Day Moving Average	2,064.46
Relative Strength Index (RSI)	52.18
Average Volume (20 Days)	738

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hester Biosciences had revenue of INR 3.16 billion and earned 234.69 million in profits. Earnings per share was 27.73.

Revenue	3.16B
Gross Profit	2.22B
Operating Income	512.71M
Pretax Income	387.38M
Net Income	234.69M
EBITDA	667.92M
EBIT	512.71M
Earnings Per Share (EPS)	27.73

Full Income Statement

Balance Sheet

The company has 167.88 million in cash and 2.44 billion in debt, giving a net cash position of -2.27 billion or -267.12 per share.

Cash & Cash Equivalents	167.88M
Total Debt	2.44B
Net Cash	-2.27B
Net Cash Per Share	-267.12
Equity (Book Value)	3.14B
Book Value Per Share	362.98
Working Capital	953.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 666.04 million and capital expenditures -234.73 million, giving a free cash flow of 431.31 million.

Operating Cash Flow	666.04M
Capital Expenditures	-234.73M
Free Cash Flow	431.31M
FCF Per Share	50.70

Full Cash Flow Statement

Margins

Gross margin is 70.30%, with operating and profit margins of 16.20% and 7.42%.

Gross Margin	70.30%
Operating Margin	16.20%
Pretax Margin	12.24%
Profit Margin	7.42%
EBITDA Margin	21.11%
EBIT Margin	16.20%
FCF Margin	13.63%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.24%.

Dividend Per Share	6.00
Dividend Yield	0.24%
Dividend Growth (YoY)	-25.00%
Years of Dividend Growth	n/a
Payout Ratio	21.75%
Buyback Yield	-7.41%
Shareholder Yield	-7.17%
Earnings Yield	1.12%
FCF Yield	2.05%

Dividend Details

Stock Splits

The last stock split was on September 27, 2012. It was a forward split with a ratio of 1.5.

Last Split Date	Sep 27, 2012
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a